Optimization of growth conditions for oxalate decarboxylase production from Pseudomonas sp. OXDC12 and in vitro inhibition of calcium oxalate crystallization by oxalate decarboxylase

2021 ◽  
Vol 10 ◽  
Author(s):  
Shruti Gupta ◽  
Shamsher S. Kanwar

Background: Kidney stones have become a common disease worldwide and their incidence and recurrence rates have drastically increased over the past few decades. Oxalate decarboxylase (OxDC) enzyme which catalyzes the disproportionation reaction of oxalate monoanions into formate and CO2 could exhibit significant potential in the treatment of hyperoxaluria. Objective: The present work describes isolation and screening of new OxDC producing bacterial strain from oxalate rich soils and one-factor-at-a-time (OFAT) and response surface methodology (RSM) statistical approaches were used to optimize the production media to obtain an improved intracellular OxDC production. Methods and Results: An OxDC producing bacterial strain isolated from spinach soil sample(s) was identified to be Pseudomonas sp. OXDC12 by 16S rRNA sequencing. The OFAT approach was used to determine the effect of supplementation of carbon, nitrogen and other physical conditions like pH, temperature etc. on intracellular OxDC production by Pseudomonas sp. OXDC12. The three factors screened by Plackett Burman design (PBD) were further used by central composite design (CCD) approach of RSM to determine their interactive effects on OxDC production. The anti-urolithiatic activity of the enzyme OxDC was determined by carrying out in vitro calcium oxalate crystallization in presence and absence of OxDC. The factorial values selected by 23 CCD for OxDC were temperature 30ºC, manganese ion concentration 5 mmol l-1 and innoculum size 3.25% (v/v). The highest predicted value of OxDC was 5.7 U ml-1 while the actual value obtained was 6.7 U ml-1 which was 79.1% and 2.92 fold greater than the initial activity of OxDC produced by Pseudomonas sp. OXDC12. As depicted by the light micrographs, OxDC displayed a significant reduction in the crystallization and formation of calcium oxalate stones as compared to the control under in vitro conditions. Conclusion: OFAT and RSM statistical optimization approaches led to improved OxDC production with a final activity of 6.7 U ml-1 and a 2.92 fold increase in the enzyme activity. The study suggests that OFAT and RSM optimization approaches significantly enhanced OxDC production from Pseudomonas sp. OXDC12. The enzyme may serve as a potential therapeutic agent for hyperoxaluria or kidney stones as it significantly inhibited the formation of calcium oxalate crystals under in vitro conditions.

2001 ◽  
Vol 37 (1) ◽  
pp. 104-112 ◽  
Author(s):  
Ryan C. Hedgepeth ◽  
Lizhu Yang ◽  
Martin I. Resnick ◽  
Susan Ruth Marengo

PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0218734 ◽  
Author(s):  
Roberta De Bellis ◽  
Maria Piera Piacentini ◽  
Maria Assunta Meli ◽  
Michele Mattioli ◽  
Michele Menotta ◽  
...  

2019 ◽  
Vol 12 (11) ◽  
pp. 5477
Author(s):  
Pradnya N. Jagtap ◽  
Bhagyashri R. Vyapari ◽  
Yashashri H. Nimbalkar ◽  
Sitaram V. Kale ◽  
Ganesh B. Nigade

2007 ◽  
Vol 40 (3) ◽  
pp. 589-594 ◽  
Author(s):  
Sevsen Kulaksızoğlu ◽  
Mustafa Sofikerim ◽  
Cemal Çevik

2011 ◽  
Vol 6 (10) ◽  
pp. 1934578X1100601
Author(s):  
Khaled Sekkoum ◽  
Abdelkrim Cheriti ◽  
Safia Taleb

Urolithiasis can lead to the loss of renal function in some cases. In this study, we tested the inhibiting effect of wheat bran ( Triticum aestivum L) extract on calcium oxalate crystallization in a turbidimetric model, by FTIR spectroscopy, and polarized microscopy. The results show that this plant extract has a major inhibitory effect on calcium oxalate crystallization.


1994 ◽  
Vol 87 (2) ◽  
pp. 137-142 ◽  
Author(s):  
Phulwinder K. Grover ◽  
Villis R. Marshall ◽  
Rosemary L. Ryall

1. Increasing the concentration of dissolved urate promotes calcium oxalate crystallization in urine from which Tamm-Horsfall mucoprotein, an inhibitor of calcium oxalate crystal aggregation, has almost completely been removed. This study aimed to determine whether the effect of urate could be reduced or abolished by a physiological concentration of Tamm-Horsfall mucoprotein. This was approached in two ways. 2. The effect of Tamm-Horsfall mucoprotein on calcium oxalate crystallization induced by urate was tested in ultrafiltered (10 kDa) urine samples from 10 healthy men. Tamm-Horsfall mucoprotein (35 mg/l) was added to half of each specimen, the urate concentration was increased by the addition of sodium urate solution and crystallization was induced by a standard load of oxalate. The remainder of each urine specimen was used as a control; these specimens were treated with an identical amount of urate solution, but contained no Tamm-Horsfall mucoprotein. Tamm-Horsfall mucoprotein had no effect on the urinary metastable limit or on the deposition of calcium oxalate, but significantly reduced the size of the particles precipitated. 3. The effect of increasing the urate concentration in the presence of Tamm-Horsfall mucoprotein was tested. Tamm-Horsfall mucoprotein (35 mg/l) was added to 10 ultrafiltered urine samples as before, the samples were divided, and the concentration of urate was increased in half of each specimen. Compared with the control to which no urate was added, urate significantly reduced the amount of oxalate required to induce spontaneous calcium oxalate nucleation and increased the median volume and the particle size of the material deposited. 4. It was concluded that, in vivo, (a) hyperuricosuria would encourage the formation of calcium oxalate stones by promoting calcium oxalate crystallization, (b) Tamm-Horsfall mucoprotein would not lessen the effect of urate on calcium oxalate nucleation or bulk deposition but would reduce its effect on crystal aggregation; it could therefore reduce the likelihood of stone formation in patients with hyperuricosuria.


Sign in / Sign up

Export Citation Format

Share Document